Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pulmonology
•
Critical Care
•
Hospital Medicine
•
General Hospital Medicine
•
Orthopedic Surgery
•
Anesthesiology
Do you routinely use systemic corticosteroids for treatment of fat embolism in patients who are hemodynamically stable?
Related Questions
What are your thoughts on trending beta-hydroxybutyrate once a diagnosis of DKA is already established?
At what initial sodium level do you recommend strict avoidance of overcorrection (e.g., no more than 6 mEq/L in 24 hours) in patients with hyponatremia?
How do you weigh the benefit of urinary catheter placement for strict I/O measurement with the risk of avoidable CAUTI?
Do you commonly observe acute erythrocytosis in patients with ILD flares being treated with supplemental oxygen and high-dose corticosteroids?
How do you weigh the risk of urinary catheter or fecal management system placement with that of soiling sacral wounds?
Would you start octreotide in a patient with suspected sulfonyurea overdose but without frank hypoglycemia?
How do you use cardiac POCUS to potentially defer formal echocardiogram in patients presenting with an acute pulmonary embolism?
How do you counsel patients on use of creatinine monohydrate supplementation during a hospitalization for acute rhabdomyolysis from intense physical training?
Do you always stop dexamethasone at discharge for patients admitted with COVID requiring respiratory support (as done in the RECOVERY trial), or are there situations in which you will prescribe it to complete a 10-day course?
Do you routinely discontinue atypical coverage in community-acquired pneumonia when PCR testing (i.e., respiratory pathogen panel) is negative for atypical organisms?
